Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46a29c70be69b917362292bc59a96743 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06 |
filingDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7f8db5effa16b0b26af6853b3234756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec84e2fa40193792d6cdd1374dfd9608 |
publicationDate |
2015-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-617764-A |
titleOfInvention |
Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome |
abstract |
The disclose relates to the use of a mixture of galactooligosaccharides which comprises disaccharides Gal(B1-3)-Glc; Gal (B1-3)-Gal; Gal (B1-6)-Gal; Gal (a1-6)-Gal; 5 trisaccharides Gal (B1-6)-Gal (B1-4)-Glc; Gal (B1-3)-Gal (B1-4)-Glc; tetrasaccharide Gal (B1-6)-Gal (B1-6)-Gal (B1-4)-Glc and pentasaccharide Gal (B1-6)-Gal (B1-6)-Gal (B1-6)Gal (B1-4)-Glc for use in preventing or reducing the risk of developing metabolic syndrome or lowering cholesterol and triglyceride levels in the blood. |
priorityDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |